Contact: Jennifer Beal sciencenewsroom@wiley.com 44-012-437-70633 Wiley People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying… Read More ›